Syncom Healthcare fixes issue price at Rs 75

Image
Press Trust of India New Delhi
Last Updated : Jan 21 2013 | 1:47 AM IST

Pharma firm Syncom Healthcare has fixed the price of its Rs 56.25 crore initial public offer at Rs 75 a piece.

The company had entered the primary market with an issue size of 75 lakh shares in the price band of Rs 65 -75 per equity share of Rs 10 each.

The offer constitutes 42.86 per cent of the fully diluted post issue paid up capital of the company, Syncom Healthcare said in a public announcement today.

The issue, which was open between January 27-29, got subscribed 5.17 times.

The IPO proceeds would be utilised to part finance the company's plan to set up a new manufacturing unit to produce formulations at the Indore Special Economic Zone.

Besides, funds will be utilised to upgrade and modernise the company's manufacturing unit at Dehradun in Uttaranchal at a cost of Rs 6.62 crore.

Chartered Capital & Investment is the sole book running lead manager to the issue.

Syncom is engaged in marketing and manufacturing of drugs and formulations. The equity shares are proposed to be listed on the Bombay Stock Exchanger and the National Stock Exchange.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 05 2010 | 2:39 PM IST

Next Story